Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $9.23M.
ENTERPRISE VALUE (EV)
$9.23M
Vyome Holdings, Inc.
Market Cap
$14.18M
Enterprise Value (EV)
$9.23M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Vyome Holdings, Inc. (HIND) | $14.18M | $9.23M |
| Obsidian Therapeutics Inc. (OBX)vs › | $14.00M | N/A |
| Sintx Technologies, Inc. (SINT)vs › | $13.99M | $13.45M |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.57M | $11.44M |
| Optimi Health Corp. (OPTH)vs › | $13.48M | $7.90M |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.18M | $3.35M |
| IN8bio, Inc. (INAB)vs › | $13.11M | N/A |
| Passage Bio, Inc. (PASG)vs › | $13.11M | N/A |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.03M | N/A |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.24M | $14.41M |
Market Cap
$14.18M
Total Debt
$31258.00
Cash
$4.98M
Enterprise Value
$9.23M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
